Servier Ventures

Servier Ventures is Servier’s wholly owned corporate venture capital fund, deploying €200 million into biotechnology and technology companies developing therapeutic approaches. It focuses on oncology and neurology, takes minority stakes, and is relevant for early-stage life sciences and pharmaceutical startups seeking strategic capital. The fund initially prioritizes Europe and has UK Series A investment activity, with access to Servier’s scientific expertise available to portfolio companies when useful.